Eliminating“Immune Fog” Shows Promise In Cancer Interception

(MENAFN- Investor Brand Network) As scientists race to find effective treatments against cancer, others are working to address tumors before they progress into full-blown cancers. A recent study conducted in the UK has found a possible way to stop cancer in its tracks during its initial stages.

Cancer interception is attracting plenty of research attention, and breakthroughs like these are helping to give the new field increasing prominence in the scientific community. Given that some mice still developed lung cancer even after being treated to clear the immune fog, advanced immunotherapies being developed by firms like Calidi Biotherapeutics Inc. (NYSE American: CLDI) can possibly help those...

Read More>>

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

MENAFN13102026000224011066ID1111802837